Skip to main content Back to Top

Compounding Conundrums: Compounding, What it IS and What it ISN’T

March 18, 2023


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

With the release of the revised USP <797> guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and extended stability. In this first episode of the series, listeners will review some of the definitions of compounding, how different regulating bodies define compounding, and how best to interpret these definitions in daily practice.


Kevin HansenKevin N. Hansen, PharmD, MS, BCSCP is director of pharmacy at Cone Health. Dr. Hansen earned his Doctor of Pharmacy degree from LECOM and completed a PGY1/PGY2 HSPAL residency program at the University of North Carolina Medical Center. He received a Master of Science degree in Pharmaceutical Sciences with a specialization in health-system pharmacy administration from the UNC Eshelman School of Pharmacy. He is board certified through the Board of Pharmacy Specialists in sterile compounding.

Terry LaurillaTerry Laurila, BS, MS, BCSCP is the home infusion/homecare pharmacy manager for Nationwide Children's Hospital in Columbus, Ohio. He graduated from The Ohio State University with his BS and MS in hospital pharmacy administration Managment with PGY2 residency at Mount Caramel Medical Center, Columbus, Ohio. He has been a hospital director of pharmacy as well involved in sterile compounding for over 30 years in both the for-profit Home Infusion national companies as well as Hospital based.

Kayleigh ThompsonKayleigh Thompson, PharmD, BCPS, BCCCP completed her Doctor of Pharmacy from The University of Texas at Austin College of Pharmacy followed by her PGY1 Pharmacy Practice and PGY2 Critical Care Residencies. She has previously worked as an emergency medicine and ICU clinical specialist in multiple adult community hospitals before becoming the Pharmacy Operations Manager at Arkansas Children’s Northwest, a growing community pediatric hospital.

James LundJim Lund, PharmD, MS, BCSCP is a senior director at Visante, Inc. and has experience in all aspects of inpatient pharmacy, including operational performance improvement, strategic planning, automation optimization, centralized service center (CSC) design and buildout, and pharmacy supply chain. Jim’s practice interests include the use of automation and technology to enhance patient safety and efficiency of pharmacy operations, strategic planning, leadership development, facility planning, and pharmacy technician practice advancement.


Compounding Conundrums: Compounding, What it IS and What it ISN'T

Compounding Conundrums: Beyond-Use Date, what a BUD IS and what a BUD ISN’T

Compounding Conundrums: Return of the BUD... What are Category 1, 2, and 3 Compounded Sterile Products? 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.